Benign conditions that mimic prostate carcinoma: MR imaging features with histopathologic correlation

YX Kitzing, A Prando, C Varol, GS Karczmar… - Radiographics, 2016 - pubs.rsna.org
Multiparametric magnetic resonance (MR) imaging combines anatomic and functional
imaging techniques for evaluating the prostate and is increasingly being used in diagnosis …

ESUR prostate MR guidelines 2012

JO Barentsz, J Richenberg, R Clements, P Choyke… - European …, 2012 - Springer
The aim was to develop clinical guidelines for multi-parametric MRI of the prostate by a
group of prostate MRI experts from the European Society of Urogenital Radiology (ESUR) …

Advances in magnetic resonance imaging: how they are changing the management of prostate cancer

A Sciarra, J Barentsz, A Bjartell, J Eastham, H Hricak… - European urology, 2011 - Elsevier
CONTEXT: Although magnetic resonance imaging (MRI) is emerging as the most commonly
used imaging modality for prostate cancer (PCa) detection, treatment planning, and follow …

Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence

K Decaestecker, G De Meerleer, B Lambert, L Delrue… - Radiation …, 2014 - Springer
Purpose To assess the outcome of prostate cancer (PCa) patients diagnosed with
oligometastatic disease at recurrence and treated with stereotactic body radiotherapy …

Salvage stereotactic body radiotherapy for patients with limited prostate cancer metastases: deferring androgen deprivation therapy

P Berkovic, G De Meerleer, L Delrue, B Lambert… - Clinical genitourinary …, 2013 - Elsevier
Background We investigated whether repeated stereotactic body radiotherapy (SBRT) of
oligometastatic disease is able to defer the initiation of palliative androgen deprivation …

Single blind randomized phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized …

IM Lips, UA van der Heide, K Haustermans… - Trials, 2011 - Springer
Background The treatment results of external beam radiotherapy for intermediate and high
risk prostate cancer patients are insufficient with five-year biochemical relapse rates of …

Prostate MR imaging for posttreatment evaluation and recurrence

S Gaur, B Turkbey - Urologic Clinics, 2018 - urologic.theclinics.com
Prostate cancer (PCa) is the most common solid organ malignancy and second most
common cause of cancer-related deaths among men in the United States. Last year …

Potential and limitations of diffusion-weighted magnetic resonance imaging in kidney, prostate, and bladder cancer including pelvic lymph node staging: a critical …

G Giannarini, G Petralia, HC Thoeny - European urology, 2012 - Elsevier
CONTEXT: Diagnosis, staging, and treatment monitoring are still suboptimal for most
genitourinary tumours. Diffusion-weighted magnetic resonance imaging (DW-MRI) has …

Detection of Recurrent Prostate Carcinoma with anti-1-Amino-3-18F-Fluorocyclobutane-1-Carboxylic Acid PET/CT and 111In–Capromab Pendetide SPECT/CT

DM Schuster, B Savir-Baruch, PT Nieh, VA Master… - Radiology, 2011 - pubs.rsna.org
Purpose To compare the diagnostic performance of the synthetic amino acid analog
radiotracer anti-1-amino-3-fluorine 18-fluorocyclobutane-1-carboxylic acid (anti-3-18F …

Prostate cancer: 1HMRS-DCEMR at 3 T versus [(18) F] choline PET/CT in the detection of local prostate cancer recurrence in men with biochemical progression after …

V Panebianco, A Sciarra, D Lisi, F Galati… - European journal of …, 2012 - Elsevier
OBJECTIVES: This study compares proton magnetic resonancespectroscopic imaging (1H-
MRSI) and dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) combined …